SCHEMBL5114750

SCHEMBL5114750

CCOC(=O)c1cnc(-c2ccccc2)nc1Oc1cc(C)ccc1C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.72
CYP2C9 P11712 3/20 0.72
CYP2C19 P33261 3/20 0.72
POLB P06746 2/20 0.72
L3MBTL1 Q9Y468 2/20 0.72
ALDH1A1 P00352 6/20 0.67
LMNA P02545 2/20 0.67
MAPT P10636 4/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
MAPK1 P28482 2/20 0.61
ATM Q13315 1/20 0.61
NPC1 O15118 2/20 0.60
RAB9A P51151 2/20 0.60
TP53 P04637 1/20 0.60
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
FOS P01100 2/20 0.50
JUN P05412 2/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5110728 0.89 CYP1A2 (0.76) CYP1A2CYP2C9CYP2C19POLBL3MBTL1
SCHEMBL5114765 0.89 CYP1A2 (0.78) CYP1A2CYP2C9CYP2C19POLBL3MBTL1
SCHEMBL5125116 0.88 MEN1 (0.64) CYP1A2CYP2C9CYP2C19POLBL3MBTL1
SCHEMBL5119871 0.87 CYP1A2 (0.66) CYP1A2CYP2C9CYP2C19POLBL3MBTL1
SCHEMBL5126255 0.85 CYP1A2 (0.77) CYP1A2CYP2C9CYP2C19POLBL3MBTL1
Orthocresol SCHEMBL6881570 0.84 CYP1A2 (0.71) CYP1A2CYP2C9CYP2C19POLBL3MBTL1
SCHEMBL5279673 0.84 ALDH1A1 (0.50) CYP1A2CYP2C9CYP2C19POLBL3MBTL1
SCHEMBL5118598 0.83 CYP1A2 (0.73) CYP1A2CYP2C9CYP2C19POLBL3MBTL1
SCHEMBL5111739 0.82 CYP1A2 (0.75) CYP1A2CYP2C9CYP2C19POLBL3MBTL1
SCHEMBL6871818 0.81 CYP1A2 (0.67) CYP1A2CYP2C9CYP2C19POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof DPYD, TYMP, TYMS CYP1A2 933/4885CYP2C9 388/4885CYP2C19 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.